SEC Form 4 · accession 0001179110-15-008139
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harold Van Wart
Officer — President and CEO · Director
Period of report
May 18, 2015
Accepted (ET)
May 19, 2015 · 7:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2015 | P | 7,300 | $3.34 | A | 7,758 | D | |
| Common Stock | May 18, 2015 | P | 100 | $3.29 | A | 7,858 | D | |
| Common Stock | May 18, 2015 | P | 100 | $3.28 | A | 7,958 | D |
Table II — derivative securities
No Table II lines on this filing.